Legal Representation
Attorney
Peter T. Wakiyama
USPTO Deadlines
Next Deadline
714 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-07-13)
Due Date
July 13, 2027
Grace Period Ends
January 13, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 13, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jun 9, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Jun 8, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
May 25, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 25, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 25, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
Feb 22, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 21, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 21, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 21, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Jul 31, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Jul 10, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
Jul 10, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jan 15, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 14, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jan 9, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jan 9, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 13, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 11, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jul 11, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 11, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 15, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 11, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 11, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jan 11, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jan 11, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 11, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jul 11, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 11, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Feb 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 20, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 20, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 5, 2018 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
Feb 5, 2018 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Feb 5, 2018 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
Feb 5, 2018 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Jan 11, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 11, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 16, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 16, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 26, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 6, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 5, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 5, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 27, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 27, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Mar 27, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Detailed Classifications
Class 009
Downloadable computer databases containing information in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology; downloadable computer databases containing medical and health information or records about or relating to humans; downloadable computer software for accessing, organizing, indexing, ranking, integrating, linking, referencing, synthesizing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans, including biomedical databases containing information about clinical, genomic, molecular, scientific and patient specific data, in particular information that clinicians and researchers enable to interpret complex molecular and genomic patient information; downloadable computer databases in the field of biomedical information, in particular links to external reference databases, in particular for the alignment and integration of biomedical information; downloadable computer software and algorithms for storing and sorting biomedical information, in particular links to external reference databases, in particular for the alignment and integration of biomedical information, updating and expanding global reference data sources across diverse medical disciplines and for allowing the immediate access to biomedical information; downloadable computer databases containing biomedical information in form of human genome sequences, information about indication and classifications of diseases, biomarkers, information about the molecular mechanism of action of drugs, their targets, metabolizing enzymes, information about scientific publications from diverse areas of biomedicine drug-to-drug interactions and the status of drug development; downloadable computer software and algorithms for authorizing or providing access to biomedical databases, in particular application software, interface software, software drives, data communication software, interactive computer software; downloadable computer software and software components for serving domain-specific user demands; downloadable mobile applications for mobile devices, such as smart phones and tablet computers, for accessing, organizing, synthesizing, indexing, ranking, integrating, linking, referencing, interpreting and analyzing information from databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals, life sciences and biotechnology and databases containing medical and health information or records about or relating to humans
First Use Anywhere:
Nov 1, 2019
First Use in Commerce:
Nov 1, 2019
Class 035
Business consulting and research services for employers in the field of employee benefits in the nature of offering medical and health care plans to employees and their family members and domestic partners for medical and health care diagnostic and treatment support programs
First Use Anywhere:
Nov 1, 2019
First Use in Commerce:
Nov 1, 2019
Class 036
Financial administration of programs and services for payment and reimbursement of employee benefits in the nature of medical and health care diagnostic and treatment support programs, for employees and their family members and domestic partners
First Use Anywhere:
Nov 1, 2019
First Use in Commerce:
Nov 1, 2019
Class 038
Providing access to searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information or records, molecular test results and patient specific data about or relating to humans for scientific research purposes; providing access to non-downloadable computer software and algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discovery, research and development; providing access to non-downloadable software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discovery, research and development purposes; providing access to non-downloadable computer software and algorithms for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and treatment purposes; providing access to software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing access to databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes
First Use Anywhere:
Nov 1, 2019
First Use in Commerce:
Nov 1, 2019
Class 042
Scientific consulting and research services in the fields of health care, medicine, life sciences, biotechnology, pharmaceuticals, bioinformatics, genomics and pharmaceuticals and pharmaceutical safety for scientific research purposes; Scientific consulting and research services for the retrieval, integration, correlation, analysis and interpretation of genomic data, sequencing data, and molecular data, disease, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discovery, research and development purposes; designing and developing and providing temporary use of online searchable databases containing medical, pharmaceutical, biological, clinical and genomic information and medical and health information or records, molecular test results and patient specific data about or relating to humans for scientific research purposes; designing and developing and providing temporary use of non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discovery, research and development; designing and developing and providing temporary use of non-downloadable software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment research and drug or pharmaceuticals or other treatment discovery, research and development purposes; software as a Service (SaaS) used in research and consulting for enabling the retrieval, integration, correlation, analysis and interpretation of genomic data, sequencing data and molecular data, disease information, biomarker information, drug protocols, drug interactions, clinical profiles, and patient specific data, molecular test results, data from clinical studies, and scientific research and health and medical information, records or data for medical, diagnostic and treatment and drug safety research and drug or pharmaceuticals or other treatment discovery, research and development purposes; provision of non-downloadable mobile applications for mobile devices, such as smart phones and tablets, and non-downloadable web applications accessible through the Internet for accessing databases in the fields of medicine, health care, genomics, bioinformatics, pharmaceuticals and pharmaceutical safety, life sciences and biotechnology; data collection services for scientific research purposes in the fields of genomics, health care, pharmaceuticals, life sciences, bioinformatics, biotechnology and medicine; scientific research services for the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing temporary use of non-downloadable computer software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data and information on diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, patient specific data, molecular test results, data from clinical studies, and scientific research for use by physicians, clinicians and other healthcare professionals, laboratory personnel, consultants, scientists and other researchers for medical diagnostic and treatment purposes; providing temporary use of non-downloadable software and algorithms for retrieval, integration, correlation, analysis and interpretation of genomic data, sequencing data and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing information in the fields of life sciences, biotechnology, bioinformatics
First Use Anywhere:
Nov 1, 2019
First Use in Commerce:
Nov 1, 2019
Class 044
Medical consulting services for the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; providing online databases containing medical, pharmaceutical, biological, clinical, molecular, sequencing and genomic information, disease information, biomarker information and medical or health information or records about or relating to humans and patient specific data, molecular test results, and scientific research for medical diagnostic and treatment purposes; medical consulting services in the fields of health, medical care, biotechnology, bioinformatics, life sciences, pharmaceuticals and medicine; providing information in the fields of health, healthcare, pharmaceuticals and pharmaceutical safety, genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing pharmaceutical information, including information about drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
First Use Anywhere:
Nov 1, 2019
First Use in Commerce:
Nov 1, 2019
Additional Information
Design Mark
The mark consists of the word "MOLECULAR" above the word "HEALTH", to the right of"MH", the "MH" being in stylized lettering consisting of elongated vertical shapes.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
009
035
036
038
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MOLECULAR HEALTH"